Idiopathic pulmonary fibrosis: Latest News, Top Stories & Analysis

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, recently announced presentation of data from …

Health / Medical

Patient Registry Breathes New Life into Pulmonary Fibrosis Research

July 25, 2019July 24, 2019 - by BPT

Over 200,000 people in the United States are living with pulmonary fibrosis (PF), a progressive, debilitating lung disease. More than 50,000 new cases of PF are diagnosed each year — …